Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, please find attached the transcript of the Investor Conference Call for Q2FY24 held on November 01, 2023.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the Investor Conference Call for Q1FY24 held on Thursday, August 03, 2023.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated July 21, 2023 under subject 'Intimation of Investor Conference Call on Q1FY24 with Senior Management of Mankind Pharma Limited', the audio recording of the Performance and Business Update Call held today i.e. 03rd August 2023 is available on the website of the Company at https://www.mankindpharma.com/media/investor/kot1320230803148085-orignal-1691059985.mp3
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the Performance and Business Update Call for Q4FY23 & FY23 held on Wednesday, 31st May 2023. The transcript is also available on the website of the Company at https://www.mankindpharma.com/media/investor/q4-fy23-transcript-1686050139.pdf
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated 25th May 2023 under subject 'Intimation of Performance and Business Update Call on Q4FY23 & FY23 with Senior Management of Mankind Pharma Limited', the audio recording of the Performance and Business Update Call held today i.e. 31st May 2023 is available on the website of the Company at https://www.mankindpharma.com/media/investor/kot1320230531147437-1685528185.mp3
